Evidence map›Paper›PMID 41031054›Full record

ReviewInternational journal of general medicine2025

Current Status of Diagnosis and Treatment of Cap Polyposis: Insights From Chinese Studies and Comparative Analysis with Japanese Cases.

Xiaobo Liu, Wen Xu, Ziye Gao, Bo Gao, Lu Zhang, Yanyan Zheng, Danqin Zhang, Yuanjun Gao, Shu Jin

Abstract readReview
In one paragraph

Review in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaobo LiuDepartment of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
Wen XuDepartment of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
Ziye GaoDepartment of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
Bo GaoDepartment of Assessment Office, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
Lu ZhangDepartment of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
Yanyan ZhengDepartment of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
Danqin ZhangDepartment of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
Yuanjun GaoDepartment of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.
Shu JinDepartment of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cap polyposis (CP) is a rare, non-neoplastic colorectal disorder characterized by inflammatory polyps with distinctive endoscopic and histopathological features. Although increasingly reported, particularly in East Asian populations, its etiology remains unclear, and diagnostic and treatment strategies are not well standardized. Previous studies have been limited by small sample sizes and regional focus. This review aims to systematically analyze the clinical characteristics, management, and outcomes of CP in Chinese patients, with comparative insights from Japanese cases, to improve understanding and guide clinical practice. Methods: A systematic literature search was conducted in PubMed, EMBASE, Cochrane Library, CNKI, and Wanfang databases for studies published before October 2023. Keywords included "cap polyposis" and "cap-shaped polyp". Articles were screened against predefined inclusion criteria: studies from Mainland China, pathologically confirmed CP cases, and availability of clinical and therapeutic data. Data extraction and quality assessment were performed independently by two reviewers using the Newcastle-Ottawa Scale. Results: Fourteen studies involving 57 patients were included. The most common symptoms were hematochezia (59.6%) and diarrhea (28.1%). Polyps were predominantly located in the rectum (68.4%), and 66.7% of patients had three or more polyps. Helicobacter pylori testing was positive in 57.1% of tested patients (12/21). Comparative analysis with Japanese cases revealed similar rectal predominance but suggested potential variations in gender distribution and treatment preferences. Treatments included endoscopic mucosal resection, endoscopic submucosal dissection, H. pylori eradication, and surgery. During a median follow-up of 14 months, 10 patients experienced recurrence. Conclusion: CP is a benign but easily misdiagnosed condition with a high recurrence rate. Diagnosis relies on combined endoscopic and histopathological findings. Treatment remains empirical, with H. pylori eradication beneficial in infected patients, and endoscopic resection effective for localized disease. Further multicenter studies are needed to establish standardized management protocols.

Indexed as

cap polyposiscap-shaped polypChinaendoscopic mucosal resectionendoscopic submucosal dissectionHelicobacter pylori

Identifiers

PMID41031054
PMCPMC12478197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.